三的使用和潜在的治疗不足在偏头痛:一个回顾性队列研究
Yael Barer1, Moshe Hoshen1, Sivan Gazit1
1Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Journal of clinical medicine
|February 27, 2026
概括
在以色列,治疗偏头痛的三药的使用率很低,停药率很高. 大多数患者在7.7个月内停止服用三药,这表明潜在的治疗不足以及需要更好的偏头痛管理策略.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 三类药物是标准的急性偏头痛治疗方法,但由于处方率低,停药率高,因此建议进行次优优化.
- 了解三的使用模式对于改善偏头痛患者护理至关重要.
研究的目的:
- 评估在以色列之前没有服用过三的患者中的三开始和停止模式.
- 为了确定影响普坦坚持和长期使用的因素.
主要方法:
- 这是一项回顾性队列研究,使用马卡比医疗保健服务 (MHS) 的10年数据 (2012-2022年).
- 对21岁以上的未曾服用过三的个体的三分发和处方数据的分析.
- 卡普兰-梅尔曲线用于评估中位时间到三断药.
主要成果:
- 在前41,297名未曾服用三的患者中,70%的患者停止服用三,中位断药时间为7.7个月.
- 大约74%的人只使用了一种三胺配方.
- 停药模式在人口统计和临床子组中一致,中位数时间一般在12个月以下.
结论:
- 高水平的断和低使用率表明以色列潜在的偏头痛治疗不足.
- 需要改善患者/医生教育和随访协议,以更好地管理偏头痛.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.9K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.9K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288


